+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ex vivo expansion of megakaryocyte progenitors from cryopreserved umbilical cord blood: A potential source of megakaryocytes for transplantation



Ex vivo expansion of megakaryocyte progenitors from cryopreserved umbilical cord blood: A potential source of megakaryocytes for transplantation



Experimental Hematology (Charlottesville) 30(9): 1079-1087



Objective. Umbilical cord blood (CB) provides an alternative source of hematopoietic progenitor cells for transplantation; however, prolonged thrombocytopenia remains a major obstacle due to the low numbers of megakaryocyte progenitor (Mk-prog) cells and their subsequent delayed engraftment. In this study, we improved techniques for enrichment, cryopreservation, and ex vivo expansion of Mk-prog cells from CB. Materials and Methods. CB mononuclear cells (MNC) were isolated and Mk-prog enriched by sedimentation on gelatin followed by centrifugation with Ficoll-Hypaque and cryopreserved. The capacity of MNC to produce Mk-prog cells, assessment of CD34+ and Mk-prog expansion in liquid culture, and analysis of the cell populations by flow cytometry were studied in cryopreserved separated CB and compared to whole CB and freshly separated samples. Results. Excellent viability of greater than 85% was maintained after cryopreservation of separated CB. The number of colony-forming Mk-prog, myeloid, and erythroid progenitor cells did not decrease with cryopreservation. Flow cytometric analysis of cryopreserved cells revealed significant removal of the residual red blood cells while maintaining complete recovery of CD34+, CD41+ (Mk), myeloid, and T and B cells compared to noncryopreserved CB cells. There was no difference in the ability of separated cryopreserved MNC CB cells to be expanded in short-term liquid cultures. Conclusions. The conditions defined here for cryopreservation of gelatin/Ficoll-Hypaque separated CB, followed by ex vivo expansion of MNC, allowed complete recovery of proliferating CD41+, CD34+, Mk-prog cells, and other hematopoietic progenitors. Mk-prog cell expansion just before the scheduled transplantation is easily applicable by this technically simple and economical procedure that requires only an aliquot of red cell cell-depleted MNC to be separated from the CB unit before cryopreservation.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010627945

Download citation: RISBibTeXText

PMID: 12225800

DOI: 10.1016/s0301-472x(02)00884-6


Related references

Preclinical ex-vivo expansion of human megakaryocyte progenitors from umbilical cord blood for transplantation using a new two-step separation procedure. Blood 92(10 Suppl. 1 Part 1-2): 310B, 1998

Expansion of megakaryocyte progenitors from cryopreserved leukocyte concentrates of human placental and umbilical cord blood in short-term liquid culture. CytoTherapy 3(2): 117-126, 2001

Ex vivo expansion of megakaryocyte progenitors from human umbilical cord blood CD34(+) cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 16(5): 1121-1125, 2008

Ex vivo expansion of hyperploid megakaryocytes from cryopreserved unfractionated leukocyte concentrates of human placental/umbilical cord blood. Blood 94(10 Suppl. 1 Part 1): 572a, 1999

Expansion of megakaryocyte clonogenic potential of fresh and cryopreserved hematopoietic stem cells from placental/umbilical cord blood. Blood 94(10 Suppl. 1 Part 2): 348b, 1999

Ex vivo expansion of umbilical cord blood cells generated from CD34+ progenitors by using a megakaryocyte-active cytokine combination. Infusion Therapy & Transfusion Medicine 28(6): 318-325, 2001

A novel method for ex-vivo expansion of NK CD3-/CD16+/56+bright/dim subsets expressing increased inhibitory receptors from cryopreserved/thawed/expanded/recryopreserved umbilical cord blood using anti-CD3, IL-2, IL-7 and IL-12 Implications for adoptive cellular immunotherapy post umbilical cord blood transplantation. Blood 102(11): 963a-964a, 2003

Clinical scale expansion of mature megakaryocytes and megakaryocyte progenitor cells from umbilical cord blood. Blood 90(10 Suppl. 1 Part 2): 340B, 1997

Clinical scale expansion of megakaryocyte progenitor cells and mature megakaryocytes from umbilical cord blood. British Journal of Haematology 102(1): 288, 1998

Ex vivo expansion, maturation, and activation of umbilical cord blood-derived T lymphocytes with IL-2, IL-12, anti-CD3, and IL-7: Potential for adoptive cellular immunotherapy post-umbilical cord blood transplantation. Experimental Hematology (Charlottesville) 30(3): 245-251, 2002

Expansion of megakaryocyte progenitors from human umbilical cord blood using a new two-step separation procedure. British Journal of Haematology 103(3): 639-650, 1998

Thrombopoietin-stimulated ex vivo expansion of megakaryocyte progenitors of human cord blood. Experimental Hematology 25(8): 897, 1997

Expansion of colony-forming unit megakaryocyte from cryopreserved leukocyte concentrates of human placental/umbilical cord blood in a short-term liquid culture. Blood 92(10 Suppl. 1 Part 1-2): 315A, 1998